Comprehensive Analysis of Gene Signatures of m6ARNA Methylation Regulators in Lung Adenocarcinoma and Development of a Risk Scoring System

Table 1

The specific baseline clinicopathological characteristics of 490 LUAD samples.

	490 LUAD samples
Age
<60 years	136
≥60 years	354
Stage
I	261
II	117
III	79
IV	25
Unknown	8
Pathologic T stage
T1-2	424
T3-4	63
Unknown	3
Pathologic N stage
N0-1	409
N2-3	70
Unknown	11
Pathologic M stage
M0	322
M1	24
Unknown	144
Survival time
≤1 years	127
1 years <; ≤3 years	273
3 years <; ≤5 years	52
>5 years	38